Ribociclib in newly diagnosed hepatitis B infection: A case report

Breast cancer is the most frequently diagnosed cancer in women worldwide. Actually CDK4/6 inhibitor Ribociclib is approved for the treatment of metastatic hormone-positive and human epidermal growth factor receptor 2 (HER 2)-negative breast cancer, but comorbidities like infectious or cardiovascular...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Costanzo, Fabrizio, Carrano, Simone, Iengo, Gennaro, Cefaliello, Amedeo, Cossiga, Valentina, Morisco, Filomena, Giuliano, Mario, De Angelis, Carmine, Arpino, Grazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285519/
https://www.ncbi.nlm.nih.gov/pubmed/37361578
http://dx.doi.org/10.3389/fonc.2023.1184952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285519/
https://www.ncbi.nlm.nih.gov/pubmed/37361578
http://dx.doi.org/10.3389/fonc.2023.1184952

Ejemplares similares